Literature DB >> 23552005

Unique presentations of epidermal growth factor receptor inhibitor-induced papulopustular eruption related to bacterial superinfection.

Lauren Elyse Wiznia1, Jennifer Nam Choi.   

Abstract

Epidermal growth factor receptor (EGFR) inhibitors have been reported to induce numerous cutaneous side effects, the most notable of which is a papulopustular eruption on the face, scalp, and central chest. The typical presentation consists of inflamed papules, often with pustules, favoring a seborrheic distribution. The pustules of the EGFR inhibitor-induced papulopustular eruption are commonly sterile but bacterial superinfection is not uncommon. We report two unique presentations of the papulopustular eruption that were found to be associated with Staphylococcus aureus superinfection. One patient presented with an abrupt onset of nearly confluent red plaques on the cheeks, forehead, chin, and neck, with innumerable studded pinpoint pustules. The other patient had a long-standing untreated papulopustular eruption on the scalp, which resulted in widespread erythema, large thick plaques of serous crust, pustular exudate, and associated alopecia. Both patients quickly resolved with non-tetracycline oral antibiotics combined with topical steroid treatment.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23552005

Source DB:  PubMed          Journal:  Dermatol Online J        ISSN: 1087-2108


  2 in total

1.  Successful treatment of epidermal growth factor receptor inhibitor-induced alopecia with doxycycline.

Authors:  Chen Amy Chen; Daniel B Costa; Peggy A Wu
Journal:  JAAD Case Rep       Date:  2015-07-30

2.  Dermatologic Toxicity Occurring During Anti-EGFR Monoclonal Inhibitor Therapy in Patients With Metastatic Colorectal Cancer: A Systematic Review.

Authors:  Mario E Lacouture; Milan Anadkat; Aminah Jatoi; Tamer Garawin; Chet Bohac; Edith Mitchell
Journal:  Clin Colorectal Cancer       Date:  2017-12-13       Impact factor: 4.481

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.